Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Purification and characterization of human antiplasmin, the fast-acting plasmin inhibitor in plasma.

× No keyword cloud information.

22 in total

Review 1. The human plasma fibrinolytic system: regulation and control.

Authors: K C Robbins
Journal: Mol Cell Biochem Date: 1978-08-16 Impact factor: 3.396

2. Purification and reaction mechanisms of the primary inhibitor of plasmin from human plasma.

Authors: U Christensen; I Clemmensen
Journal: Biochem J Date: 1978-11-01 Impact factor: 3.857

Review 3. Streptokinase--the drug of choice for thrombolytic therapy.

Authors: Adinarayana Kunamneni; Thaer Taleb Abed Abdelghani; Poluri Ellaiah
Journal: J Thromb Thrombolysis Date: 2007-02 Impact factor: 2.300

4. Full time course kinetics of the streptokinase-plasminogen activation pathway.

Authors: Miranda Nolan; Samantha D Bouldin; Paul E Bock
Journal: J Biol Chem Date: 2013-08-22 Impact factor: 5.157

5. Plasminogen interacts with human platelets through two distinct mechanisms.

Authors: L A Miles; M H Ginsberg; J G White; E F Plow
Journal: J Clin Invest Date: 1986-06 Impact factor: 14.808

6. Alpha2-plasmin inhibitor and alpha2-macroglobulin-plasmin complexes in plasma. Quantitation by an enzyme-linked differential antibody immunosorbent assay.

Authors: P C Harpel
Journal: J Clin Invest Date: 1981-07 Impact factor: 14.808

7. Alpha 2-antiplasmin supplementation inhibits tissue plasminogen activator-induced fibrinogenolysis and bleeding with little effect on thrombolysis.

Authors: J I Weitz; B Leslie; J Hirsh; P Klement
Journal: J Clin Invest Date: 1993-04 Impact factor: 14.808

8. PAI-1 leads to G1-phase cell-cycle progression through cyclin D3/cdk4/6 upregulation.

Authors: Evan Gomes Giacoia; Makito Miyake; Adrienne Lawton; Steve Goodison; Charles J Rosser
Journal: Mol Cancer Res Date: 2014-01-24 Impact factor: 5.852

9. Evidence of normal functional levels of activated protein C inhibitor in combined Factor V/VIII deficiency disease.

Authors: W M Canfield; W Kisiel
Journal: J Clin Invest Date: 1982-12 Impact factor: 14.808

10. Inactivation of key factors of the plasma proteinase cascade systems by Bacteroides gingivalis.

Authors: T Nilsson; J Carlsson; G Sundqvist
Journal: Infect Immun Date: 1985-11 Impact factor: 3.441